Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Cara Therapeutics, Inc. (CARA) will host a conference call on March 4, 2024, to report Q4 and full year 2023 financial results. Registrants can access the call via webcast or dial-in numbers. The event will provide a corporate update.
02/12/2024 - 04:01 PM
STAMFORD, Conn., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) today announced the Company will host a conference call and live audio webcast on Monday, March 4, 2024, at 4:30 p.m. EST to report fourth quarter and full year 2023 financial results and provide a corporate update.
To participate in the conference call, please register here . Registrants will receive the dial-in numbers and a unique PIN.
A live audio webcast and archived replay of the call will be available under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com .
About Cara Therapeutics
Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin, with an ongoing Phase 2/3 clinical program for patients with notalgia paresthetica, a neuropathic disorder characterized by chronic pruritus of the upper back for which there are no FDA-approved therapies. For more information, visit www.CaraTherapeutics.com and follow the company on X (Twitter) , LinkedIn and Instagram .
MEDIA CONTACT: aspinetta@6degreespr.com
INVESTOR CONTACT: investor@caratherapeutics.com
When will Cara Therapeutics host a conference call to report Q4 and full year 2023 financial results?
Cara Therapeutics will host a conference call on March 4, 2024.
How can participants access the conference call?
Participants can access the call via webcast or dial-in numbers.
Where can registrants find the archived replay of the conference call?
Registrants can find the archived replay under 'Events & Presentations' on Cara Therapeutics' website.
What is the ticker symbol for Cara Therapeutics?
The ticker symbol for Cara Therapeutics is CARA.
CARA Rankings
#5448 Ranked by Stock Gains
CARA Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Stamford
About CARA
cara therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. cara's most advanced patented compound, cr845, is currently undergoing clinical testing for acute pain and uremic pruritus. this compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. in addition, cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
